Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors
ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age45-70
SponsorUniversity of Belgrade
About this trial
This project aims to decrease undesirable side effects and increase qulaity of life of aromatase inhibitors therapy in breast cancer survivors, by anti-inflammatory diet or supplementation.
Eligibility criteria
Qualifiers
Age: 45 to 70 years
Postmenopausal women
Histologically confirmed BRC, stage I to IIIa
ER positive /HER2 negative
Disqualifiers
Metastatic or locally advanced disease
HER2-positive tumors
Presence of other malignant or serious chronic diseases
Active infections
Trial design
Treatments tested in this trial
- Supplement
- AI diet
- Placebo
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov